APUS
AMEX · Biotechnology
Apimeds Pharmaceuticals Us I
$0.90
-0.03 (-2.70%)
Open$1.01
Previous Close$0.93
Day High$1.01
Day Low$0.78
52W High$40.31
52W Low$0.79
Volume—
Avg Volume93.7K
Market Cap13.58M
P/E Ratio—
EPS$-6.34
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 11.55M | 12.01M | 11.14M |
| Net Income | 858.8K | 710.2K | 724.1K |
| Profit Margin | 7.4% | 5.9% | 6.5% |
| EBITDA | 1.04M | 1.13M | 1.04M |
| Free Cash Flow | 935.0K | 714.0K | 1.10M |
| Rev Growth | -8.4% | +17.9% | -7.5% |
| Debt/Equity | 0.40 | 0.38 | 0.40 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |